Federal Register Notices > Rules - 1999 > Chemical Registration and Reregistration Fees Rules - 1999
[Federal Register: December 1, 1999 (Volume 64, Number 230)] DEPARTMENT OF JUSTICE Drug Enforcement Administration [DEA NUMBER 185-P] Chemical Registration and Reregistration Fees AGENCY: Drug Enforcement Administration (DEA), Justice. ACTION: Proposed rule. SUMMARY: The Drug Enforcement Administration (DEA) proposes to amend its application fees for registration and reregistration of manufacturers, distributors, importers, and exporters of List I chemicals, as authorized by section 3(a) of the Domestic Chemical Diversion Control Act of 1993 (DCDCA), reducing the fees from $595 to $326 for initial registration, and the reregistration fees from $477 to $171. Fees for retail registrants will increase from $255 to $326 for registration, and from $116 to $171 for reregistration. Office of Management and Budget (OMB) Circular A-25 requires a periodic review of user charges for agency programs. This review will bring fees into alignment with current changes in costs or market values. DATES: Written comments or objections must be submitted on or before January 31, 2000. ADDRESSES: Comments and objections should be submitted in quintuplicate to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, Washington, DC 20537, Attention: DEA Federal Register Representative/CCR. FOR FURTHER INFORMATION CONTACT: Patricia Good, Chief, Liaison and Policy Section, Office of Diversion Control, Drug Enforcement Administration, Washington, DC 20537. Telephone (202) 307-7297. SUPPLEMENTARY INFORMATION: Impact of the Proposed Rule What Is the Effect of This Proposed Rule, and to Whom Does It Apply? The Drug Enforcement Administration (DEA) proposes to reduce the registration and [[Page 67217]] reregistration fees for persons manufacturing, distributing (non-retail), importing and exporting List I chemicals. There are currently 3,685 such registrants. Fees are reduced from $595 to $326 for registration, and from $477 to $171 for reregistration. Registration and reregistration fees for the 47 current retail registrants increase slightly, from $255 to $326 for registration, and from $116 to $171 for reregistration. At this time, DEA is receiving, on average, fewer than the new retail applications per year. Legislative History What is the Legal Basis for Registering Persons Manufacturing, Distributing, Importing and Exporting List I Chemicals The Chemical Diversion and Trafficking Act (CDTA) of 1988 was passed by Congress to control the diversion of certain chemicals that are necessary for the illicit manufacture of controlled substances. The CDTA and its regulations, set forth in Title 21 Code of Federal Regulations (CFR) parts 1310 and 1313, established a system of record keeping and reporting requirements through which DEA and the chemical industry could identify persons seeking to divert listed chemicals for the manufacture of illicit controlled substances. The Domestic Chemical Diversion Control Act of
1993 (DCDCA), which became effective on April 16, 1994, established a
number of new requirements intended to close avenues used by illicit
controlled substance manufacturers to circumvent the CDTA. One of the
main Concurrent with the establishment of the registration requirement, DEA established, by regulations, the fees to be charged for registration and reregistration of List I chemical handlers, as required under the Independent Offices Appropriations act (IOAA) and the guidelines set forth in the Office of Management and Budget (OMB) Circular A-25. OMB Circular A-25, Section 6 provides that "[A] user charge * * * will be assessed against each identifiable recipient for special benefits derived from Federal activities beyond those received by the general public.'' The section further requires that the user charge be sufficient to "* * * recover the full cost to the Federal Government for providing the special benefit.'' A special benefit is described as a Government service which "Enables the beneficiary to obtain more immediate or substantial gains or values (which may or may not be measurable in monetary terms) than those that accrue to the general public (e.g., receiving a patient, insurance, or guarantee provision, or a license to carry on a specific activity or business [emphasis added] or various kinds of public land use).'' Sections 822 and 957 of Title 21, United States Code, as amended by the DCDCA, require that any person who manufactures, distributes, imports or exports a List I chemical must obtain annually a registration in accordance with DEA rules and regulations. A registration to manufacture, distribute, import or export List I chemicals is a special benefit under Circular A-25, in that it allows the registrant to engage in certain activities while a member of the general public may not. Therefore, the costs associated with DEA's issuance of a registration to manufacture, distribute, import or export a List I chemical; certain costs associated with advising registrants of their responsibilities; and maintenance of the integrity of the registration system must be recovered through assessment of a user fee. Section 6(d) of Circular A-25 describes the requirements for determining the full cost of a service or benefit. "Full cost'' is defined as all direct and indirect costs, including, but not limited to: direct and indirect personnel costs, including salaries, fringe benefits (such as life and health insurance and retirement) and travel; physical overhead, including material and supply costs, rent and utilities; management and supervisory costs; and the costs of enforcement, collection, research, establishment of standards, and regulations. Section 6(d)(1)(e) provides that the cost figures shall be established utilizing "the best available records of the agency, and new cost accounting systems need not be established solely for this purpose.'' The costs of the services provided by DEA were determined by use of proven and accepted budget estimating techniques as outlined in the DOJ budget guidelines and OMB Circular A-11. Initial Fee Implementation How did DEA Implement the Initial Fees DEA established two distinct categories of chemical registrants: retail distributors, such as convenience stores, gas stations, truck stops, liquor stores, etc., whose regulated activities consist of the direct sales to walk-in customers of drug products that are regulated as List I chemicals; and non-retail registrants, such as manufacturers which distribute, distributors, importers, and exporters of List I chemicals. Each category of registrant was addressed independently during the original establishment of the fees. Establishment of the initial application fee was a simple matter since the costs associated with the processing of each application for registration were direct costs applicable to each individual application; there were minimal general program costs that were required to be averaged across the applicant population. For renewal applications the calculation of the fee required identification of general program maintenance costs which were to be averaged across the registrant population. However, because List I chemical registration was a new requirement, there was no existing registrant population and the fees had to be calculated based on estimates of the potential population. For purposes of calculating the fee DEA estimated 10,000 retail registrants and 1,500 non-retail registrants. Full details regarding the calculation of the original fees are contained in DEA's proposed rule regarding Implementation of the Domestic Chemical Diversion Control Act of 1993 (Pub. L. 103-200) which was published in the Federal Register on October 13, 1994 (59 FR 51887). New Applications What Factors Were Involved in Establishing New Application Fees Due to industry comments regarding the financial impact of the registration fee received at the time the requirements of the MCA were implemented, DEA reviewed the preregistration process and waived a significant portion of the initial registration fee for manufacturers, distributors, importers, and exporters of regulated drug products, requiring that only $116 of the $595 fee be paid. Notice regarding the fee waiver was published in the Federal Register on October 17, 1997 (62 FR 53958). Since that time, DEA has continued to assess the situation and has become aware of a number of incidents involving the theft of significant quantities of drug products and raw materials from persons distributing controlled substances and listed chemicals. At least five million dosage units of drug products and 75 kilograms of pseudoephedrine powder have been reported stolen. DEA is concerned that with the emphasis placed on "knowing the customer'' and ensuring that all sales are legitimate, there may be [[Page 67218]] insufficient emphasis placed on maintaining security of the listed chemicals that registrants have in their possession. It is clear that a strong DEA presence at the time of initial registration remains necessary to ensure that applicants are fully aware of all requirements, not only in terms of "knowing the customer'' and ensuring that sales are legitimate, but also ensuring that appropriate safeguards are in place to prevent theft or diversion of listed chemicals from the regulated location. However, while DEA will continue to conduct on-site activities as part of the preregistration investigation, at this time, due to the demand on resources for the pursuit of criminal investigations, DEA will only be able to allocate six hours of investigative time for each preregistrant investigation. However, DEA anticipates that, over time, these demands will lessen and resources currently dedicated to criminal investigations will be reallocated to other chemical regulatory activities, including preregistration investigations. DEA will reexamine chemical registration and reregistration fees when this reallocation of resources occurs. Reregistration Applications What Factors Were Involved in Establishing Reregistration Application Fees Two factors have affected the calculation of the reregistration fees. First, due to the continued demand for resources for the pursuit of investigations, DEA anticipates dedicating a total of six investigator work years to regulatory audits of both retail and non-retail registrants. Second, the actual non-retail registrant population is greater than the originally estimated population of 1,500 registrants, due in part to the expanded registration requirements of the MCA. At the time of drafting of this notice, there are 47 retail registrants and 3,685 non-retail registrants, for a total of 3,732 chemical registrants. Fees What Specific Costs Were Included in the Calculation of the Fees? DEA utilized the standard modular costing method used throughout the federal government to calculate fees. This methodology relates costs to the number of personnel within the program and accounts for inflationary increase. Funding for salaries, benefits, equipment, training, and other position-related expenses is predicted on the modular formula which is reviewed and revised each budget year by the Department of Justice (DOJ) and OMB, the latter having ultimate authority in finalizing the formula for each fiscal year. As previously stated, the personnel costs listed below include all direct and indirect costs, including salaries, fringe benefits (such as life and health insurance and retirement) and travel; physical overhead, including material and supply costs such as forms, postage, equipment, rent and utilities. Direct costs are those costs which are apportionable to a specific registration or reregistration application, i.e., direct personnel and materials costs, whereas indirect costs are costs not directly apportionable to a specific registration or reregistration application, i.e., managerial, regulatory, and supervisory costs. In light of the minimal number of retail registrants (47), the fact that direct costs are the same for retail and non-retail registrants, and the indirect costs are averaged across the entire retail/non-retail registrant population, DEA has determined that the initial fee for retail and non-retail registrants can be calculated together rather than separately, and that the renewal fee for retail and non-retail registrants can be calculated together rather than separately. Based on the costs as laid out in the following tables, the initial registration fee will be $326.00, and the reregistration fee will be $171.00. Costs for Processing an Application and Issuing an Initial Registration Direct Costs:
Indirect Costs:
Notes Regarding the Costs Associated With Issuance of an Initial Registration
[[Page 67219]]
Because the Management/Supervisory costs are related to the general operation of the registration program, they must be averaged across the entire applicant population. For 3,732 applicants, the average cost would be $23.87.
Cost for Processing a Reregistration Application Direct Costs: Indirect Costs:
Notes Regarding the Costs Associated With Reregistration
Because the Management/Supervisory costs are related to the general operation of the registration program, they must be averaged across the entire reregistration applicant population. DEA has received 3,732 retail and non-retail reregistration applications. The average cost per applicant would be $23.87.
Refund of Fees for Certain Registrants Section 8(e) of OMB Circular A-25 requires periodic review of user fees. DEA's initial review of these fees in 1997 was delayed due to passage of the Comprehensive Methamphetamine Control Act of 1996 (MCA) which significantly expanded the scope of the registration requirement. DEA postponed the review of the fees until all persons affected by the MCA had submitted their applications. Due to this delay, there are registrants who have been required to pay the full reregistration fee of $477.00. DEA will [[Page 67220]] be making arrangements to refund the difference between the current and proposed reregistration fees. Refunds will be provided to those registrants who have renewed their registration in the year preceding the effective date of the final rule published in conjunction with this notice. Refunds will only be provided to those registrants who renewed their registration on time, not those applicants who, by virtue of renewing late, fell into this payment period. Regulatory Certifications Regulatory Flexibility Act The Deputy Assistant Administrator hereby certifies that this proposed rulemaking has been drafted in a manner consistent with the principles of the Regulatory Flexibility Act (5 U.S.C. 601 et seq.). It will not have a significant economic impact on a substantial number of small business entities. This notice reduces the registration and reregistration fee substantially for the larger portion of the industry, i.e., those persons required to submit applications for renewal of registration, reducing the registration fee from $595 to $326, and the reregistration fee from $447 to $171, providing economic relief to the small businesses affected. With respect to the one category of fee that increased, for retail distributors, there are currently less than 50 retail distributor registrants and DEA is receiving, on average, less than 10 new applications from retail distributors per year. Executive Order 12866 The Deputy Assistant Administrator further certifies that this rulemaking has been drafted in accordance with the principles of Executive Order 12866 Section 1(b). DEA has determined that this is not a significant regulatory action. As noted above, this proposed rule reduces the existing fee structure for most registrants, thus providing economic relief to the registrant population. DEA has determined that this rulemaking is not significant. Therefore, it has not been submitted to the Office of Management and Budget for review. Executive Order 13132 This action has been analyzed with the principles and criteria in Executive Order 13132, and it has been determined that this rule does not have sufficient federalism implications to warrant the preparation of a Federalism assessment. Unfunded Mandates Reform Act of 1995 This rule will not result in the expenditure by state, local, and tribal governments in the aggregate, or by the private sector, of $100 million or more in any one year, and will not significantly or uniquely affect small governments. Therefore, no actions were deemed necessary under the provisions of the Unfunded Mandates Reform Act of 1995. Small Business Regulatory Enforcement Fairness Act of 1996 This rule is not a major rule as defined by Section 804 of the Small Business Regulatory Enforcement Fairness Act of 1996. This rule will not result in an annual effect on the economy of $100 million or more; a major increase in costs or prices; or significant adverse effects on competition, employment, investment, productivity, innovation or on the ability of United States-based companies to compete with foreign-based companies in domestic and export markets. Plain Language Instructions The Drug Enforcement Administration makes every effort to write clearly. If you have suggestions as to how to improve the clarity of these regulations, call or write Patricia Good, Chief, Liaison and Policy Section, Office of Diversion Control, Drug Enforcement Administration, Washington, DC 20537. Telephone (202) 307-7297. List of Subjects in 21 CFR Part 1309 Administrative practice and procedure, Drug traffic control, List I and List II chemicals, Security measures For the reasons set out above, 21 CFR Part 1309 is proposed to be amended as follows: PART 1309--[AMENDED]
Authority: 21 U.S.C. 821, 822, 823, 824, 830, 871(b), 875, 877, 958.
§ 1309.11 Fee amounts. (a) For each initial registration to manufacture for distribution, distribute (either retail distribution or non-retail distribution), import, or export a List I chemical, the applicant shall pay a fee of $326 for an annual registration. (b) For each reregistration to manufacture for distribution, distribute (either retail distribution or non-retail distribution), import, or export a List I chemical, the registrant shall pay a fee of $171 for an annual registration.
§ 1309.12 Time and method of payment; refund. (a) For each application for registration or reregistration to manufacture for distribution, distribute (either retail distribution or non-retail distribution), import, or export a List I chemical, the applicant shall pay the fee when the application for registration or reregistration is submitted for filing. (b) Payment should be made in the form of a personal, certified, or cashier's check or money order made payable to "Drug Enforcement Administration.'' Payments made in the form of stamps, foreign currency, or third party endorsed checks will not be accepted. These application fees are not refundable. Dated: October 1, 1999. John H. King, [FR Doc. 99-30960 Filed 11-30-99; 8:45 am]
Registration
Support
|